Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepafenac versus dexamethasone after uncomplicated cataract surgery
PACTR201701001971511Completed
- Sponsor
- Ochuko Egagifo
- Start
- Feb 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Trial of nepafenac and dexamethasone in Postoperative ocular inflammation and cataract (2 arms), sponsored by Ochuko Egagifo. Primary endpoints: anterior chamber cells and flare and intraocular pressure. Started Feb 2016; status: completed.
02
Drugs
nepafenacdexamethasone
03
Conditions
Postoperative ocular inflammationcataract
Beyond the preview
Go deeper on PACTR201701001971511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201701001971511.